Literature DB >> 24902989

DSM-5-defined 'mixed features' and Benazzi's mixed depression: which is practically useful to discriminate bipolar disorder from unipolar depression in patients with depression?

Minoru Takeshima1, Takashi Oka.   

Abstract

AIMS: Irritability, psychomotor agitation, and distractibility in a major depressive episode (MDE) should not be counted as manic/hypomanic symptoms of DSM-5-defined mixed features; however, this remains controversial. The practical usefulness of this definition in discriminating bipolar disorder (BP) from major depressive disorder (MDD) in patients with depression was compared with that of Benazzi's mixed depression, which includes these symptoms.
METHODS: The prevalence of both definitions of mixed depression in 217 patients with MDE (57 bipolar II disorder, 35 BP not otherwise specified, and 125 MDD cases), and their operating characteristics regarding BP diagnosis were compared.
RESULTS: The prevalence of both Benazzi's mixed depression and DSM-5-defined mixed features was significantly higher in patients with BP than it was in patients with MDD, with the latter being quite low (62.0% vs 12.8% [P < 0.0001], and 7.6% vs 0% [P < 0.0021], respectively). The area under the receiver operating curve for BP diagnosis according to the number of all manic/hypomanic symptoms was numerically larger than that according to the number of manic/hypomanic symptoms excluding the above-mentioned three symptoms (0.798; 95% confidence interval, 0.736-0.859 vs 0.722; 95% confidence interval, 0.654-0.790). The sensitivity/specificity of DSM-5-defined mixed features and Benazzi's mixed depression for BP diagnosis were 5.1%/100% and 55.1%/87.2%, respectively.
CONCLUSIONS: DSM-5-defined mixed features were too restrictive to discriminate BP from MDD in patients with depression compared with Benazzi's definition. To confirm this finding, studies that include patients with BP-I and using tools to assess manic/hypomanic symptoms during MDE are necessary.
© 2014 The Authors. Psychiatry and Clinical Neurosciences © 2014 Japanese Society of Psychiatry and Neurology.

Entities:  

Keywords:  DSM-5; bipolar disorder; depression; mixed depression; mixed states

Mesh:

Year:  2014        PMID: 24902989     DOI: 10.1111/pcn.12213

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  11 in total

Review 1.  Issues on the diagnosis and etiopathogenesis of mood disorders: reconsidering DSM-5.

Authors:  Kazuyoshi Ogasawara; Yukako Nakamura; Hiroyuki Kimura; Branko Aleksic; Norio Ozaki
Journal:  J Neural Transm (Vienna)       Date:  2017-12-23       Impact factor: 3.575

2.  The prevalence and diagnostic classification of mixed features in patients with major depressive episodes: A multicenter study based on the DSM-5.

Authors:  In Hee Shim; Jonghun Lee; Moon-Doo Kim; Young-Eun Jung; Kyung Joon Min; Young-Joon Kwon; Ji Sun Kim; Kwanghun Lee; Young Sup Woo; Beomwoo Nam; Jeong Seok Seo; Jung Goo Lee; Duk-In Jon; Inki Sohn; Sung-Yong Park; Bo-Hyun Yoon; Won-Myong Bahk
Journal:  Int J Methods Psychiatr Res       Date:  2019-02-20       Impact factor: 4.035

3.  Validity of the Shahin Mixed Depression Scale: A Self-Rated Instrument Designed to Measure the Non-DSM Mixed Features in Depression.

Authors:  Islam Shahin; Caterina Del Mar Bonnin; Elsayed Saleh; Khaled Helmy; Usama M Youssef; Eduard Vieta
Journal:  Neuropsychiatr Dis Treat       Date:  2020-09-28       Impact factor: 2.570

4.  Treatment of mixed depression with theta-burst stimulation (TBS): results from a double-blind, randomized, sham-controlled clinical trial.

Authors:  Diego Freitas Tavares; Paulo Suen; Carla Garcia Rodrigues Dos Santos; Doris Hupfeld Moreno; Leandro Da Costa Lane Valiengo; Izio Klein; Lucas Borrione; Pamela Marques Forte; André R Brunoni; Ricardo Alberto Moreno
Journal:  Neuropsychopharmacology       Date:  2021-06-30       Impact factor: 7.853

Review 5.  Atypical Antipsychotics in the Treatment of Acute Bipolar Depression with Mixed Features: A Systematic Review and Exploratory Meta-Analysis of Placebo-Controlled Clinical Trials.

Authors:  Michele Fornaro; Brendon Stubbs; Domenico De Berardis; Giampaolo Perna; Alessandro Valchera; Nicola Veronese; Marco Solmi; Licínia Ganança
Journal:  Int J Mol Sci       Date:  2016-02-16       Impact factor: 5.923

6.  Efficacy, Safety, and Tolerability of Theta-Burst Stimulation in Mixed Depression: Design, Rationale, and Objectives of a Randomized, Double-Blinded, Sham-Controlled Trial.

Authors:  Diego Freitas Tavares; Carla Garcia Rodrigues Dos Santos; Leandro Da Costa Lane Valiengo; Izio Klein; Lucas Borrione; Pamela Marques Forte; Andre R Brunoni; Ricardo Alberto Moreno
Journal:  Front Psychiatry       Date:  2020-05-15       Impact factor: 4.157

7.  Association between anxious distress in a major depressive episode and bipolarity.

Authors:  Hiroko Sugawara; Takahiro Tsutsumi; Ken Inada; Jun Ishigooka; Mamoru Hashimoto; Minoru Takebayashi; Katsuji Nishimura
Journal:  Neuropsychiatr Dis Treat       Date:  2019-01-15       Impact factor: 2.570

8.  Development of the 12-item questionnaire for quantitative assessment of depressive mixed state (DMX-12).

Authors:  Hotaka Shinzato; Munenaga Koda; Akifumi Nakamura; Tsuyoshi Kondo
Journal:  Neuropsychiatr Dis Treat       Date:  2019-07-15       Impact factor: 2.570

Review 9.  The State of the Art of the DSM-5 "with Mixed Features" Specifier.

Authors:  Norma Verdolini; Mark Agius; Laura Ferranti; Patrizia Moretti; Massimiliano Piselli; Roberto Quartesan
Journal:  ScientificWorldJournal       Date:  2015-08-25

Review 10.  Mixed Depression: A Mini-Review to Guide Clinical Practice and Future Research Developments.

Authors:  Antimo Natale; Ludovico Mineo; Laura Fusar-Poli; Andrea Aguglia; Alessandro Rodolico; Massimo Tusconi; Andrea Amerio; Gianluca Serafini; Mario Amore; Eugenio Aguglia
Journal:  Brain Sci       Date:  2022-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.